Biocon Gets FDA Observations At Key Biosimilars Facilities

US Agency Finds Multiple Form 483 Deficiencies Across Bengaluru And Malaysia Sites

 
• By Dave Wallace
  
483 3D numbers green background
Biocon has received multiple Form 483 observations across three facilities • Source: Shutterstock

More from Manufacturing

More from Business